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ABSTRACT 
 
Sentinel lymph node biopsy (SLNB) has emerged as an accurate, less invasive alternative to 
axillary lymph node dissection, and it has rapidly become the standard of care for patients with 
clinically node-negative breast cancer. The sentinel lymph node (SLN) hypothesis states that the 
pathological status of the axilla can be accurately predicted by determining the status of the first 
(i.e., sentinel) lymph nodes that drain from the primary tumor. Physicians use radio-labeled 
sulfur colloid and/or methylene blue dye to identify the SLN, which is most likely to contain 
metastatic cancer cells. However, the surgical procedure causes morbidity and associated 
expenses. To overcome these limitations, we developed a dual-modality photoacoustic and 
ultrasound imaging system to noninvasively detect SLNs based on the accumulation of 
methylene blue dye. Ultimately, we aim to guide percutaneous needle biopsies and provide a 
minimally invasive method for axillary staging of breast cancer. The system consists of a tunable 
dye laser pumped by a Nd:YAG laser, a commercial ultrasound imaging system (Philips iU22), 
and a multichannel data acquisition system which displays co-registered photoacoustic and 
ultrasound images in real-time. Our clinical results demonstrate that real-time photoacoustic 
imaging can provide sensitive and specific detection of methylene blue dye in vivo. While 
preliminary studies have shown that in vivo detection of SLNs by using co-registered 
photoacoustic and ultrasound imaging is feasible, further investigation is needed to demonstrate 
robust SLN detection. 
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1. INTRODUCTION 
 
The detection of regional lymph node metastases is important in cancer staging as it 
influences the prognosis of the patient and the strategy for treatment. Sentinel lymph node biopsy 
(SLNB) has emerged as the standard of care for axillary staging of clinically node-negative 
breast cancer [1,2].  The sentinel node hypothesis states that the histopathologic status of the first 
(i.e., sentinel) node on the lymphatic drainage pathway from a primary tumor reflects the 
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pathological status of the axilla. Besides the presence of metastasis or micrometastasis detected 
in the sentinel lymph node (SLN) after excision and histological examination, the total number 
of involved regional lymph nodes is important in staging the disease, with the number predicting 
overall survival with an inverse relationship [3].  
Typically, the conventional SLNB procedure consists of injecting radioactive tracers and/or 
methylene blue dye to mark the lymphatic system and guide the surgeon to the sentinel node. 
The radioactive tracer is injected a few hours prior to the surgery, while methylene blue, which 
spreads relatively quickly through lymph vessels, is injected in the operating room. A few 
minutes following methylene blue injection, a surgical incision is made in the area indicated by a 
hand-held Geiger counter. The surgeon interrogates the axilla and identifies nodes that have been 
stained blue or nodes that are detected as radioactive with the Geiger counter. These nodes are 
then removed for histological examination to determine the presence of tumor metastases. 
Here, we propose the use of dual-modality photoacoustic tomography (PAT) [4-7] and 
ultrasonography (US) for accurate identification of SLNs. The US component of PAT-US 
enables the anatomical identification of lymph nodes, while the PAT component determines if 
the lymph node is a SLN by imaging  accumulated blue dye. Unlike US, PAT is very sensitive to 
the strong optical absorption of the blue dye. PAT also has higher spatial resolution in deep 
tissues than pure optical imaging modalities. An accurate identification of SLN by PAT-US can 
allow sampling of the SLN using fine needle aspiration biopsy (FNAB). 
 
 
2. MATERIALS AND METHODS  
 
2.1 Photoacoustic and ultrasound imaging system 
We developed a photoacoustic tomography (PAT) and ultrasound (US) imaging system 
around a modified clinical US scanner (iU22, Philips Healthcare). A system diagram is shown in 
Fig. 1. The light source consisted of a wavelength tunable dye laser (PrecisionScan-P, Sirah, 
Kaarst, Germany) pumped by a Q-switched Nd:YAG laser (QuantaRay PRO-350-10, Spectra-
Physics, Santa Clara, CA). The laser pulse was coupled to a fused end, bifurcated fiber bundle 
that flanked both sides of commercially available Philips transducers (L12-5 and L8-4, Philips), 
(Fig. 2). The laser emitted pulses at a repetition rate of 10 Hz and pulse duration of 6.5 ns.  An 
optical wavelength near the peak absorption wavelength of methylene blue dye (667 nm) was 
chosen, and light fluence on the skin was less than 10 mJ/cm2, which was within the ANSI safety 
limits by a factor of 2 [8]. All per-channel data from the US transducer were transferred to a 
custom-built data acquisition (DAQ) computer, which performed image reconstruction and 
displayed PA and US and co-registered images at 5 frames/s. 
 
2.2 Clinical study 
First, a periareolar injection of methylene blue dye was administered as a PAT contrast agent 
to highlight the SLN. Since methylene blue is commonly used clinically for SLN biopsy, the 
PAT imaging method builds on the proven track record and physician experience with the dye 
for SLN detection. Methylene blue dye drains into the sentinel node within minutes of injection, 
although lymphatic flow can be accelerated using breast massage. Next, axillary PAT-US 
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Modified Ultrasound
System (IU22)
Display
PA/US
imaging is performed. US imaging detects lymph nodes based on their characteristic appearance 
(hypoechoic outer cortex and hyperechoic central hilum), while PAT distinguishes sentinel nodes 
from downstream nodes based on strong photoacoustic contrast from methylene blue.  
 
 
 
 
 
 
Figure 1. Schematic of the dual-modality photoacoustic and ultrasound imaging system and 
improved transducer design.  
 
 
 
 
 
 
 
Figure 2. Hand-held PAT-US probe. The transducer features a flat surface for light delivery, and 
fiber bundles are integrated into the transducer housing for easier handling. 
 
 
 
PA/US Probe 
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3. IN VIVO CLINICAL RESULTS  
 
Study participants received a single subcutaneous injection of methylene blue dye (5 mL, 2 
mg/mL) with a 25 gauge needle near the areola in the same breast quadrant as the primary tumor. 
This technique was comparable to current methods utilized during routine SLNB. The breast was 
manually massaged for approximately 5 minutes to facilitate lymphatic flow to the axilla. PAT-
US imaging of the axilla was performed following methylene blue administration to identify the 
accumulation of methylene blue in suspected SLNs.  
Figures 3a and 3b show corresponding US and PAT images, respectively, revealing a SLN. 
The co-registered PAT and US image (Figure 3c) shows the capability of the technology to 
locate lymph nodes via anatomical features in US, and to verify the lymph node as a sentinel 
node using PAT.  
 
 
 
 
Figure 3. (a) In vivo US image of lymph node, (b) In vivo PAT image represented by optical 
absorption of methylene blue, (c) corresponding co-registered PAT-US image of the SLN. 
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4. CONCLUSIONS 
 
We successfully developed a dual-modality imaging system that integrates PAT and 
ultrasonography.  Our preliminary results show that co-registered PAT and US imaging can 
detect SLNs in real-time. This approach offers significant benefits over the current standard of 
care; specifically, it would avoid the morbidity of the surgical SLNB technique and eliminate the 
need for radioactive isotopes in lymph node staging. 
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